Bertaut, A., Truntzer, C., Madkouri, R., Kaderbhai, C. G., Derangère, V., Vincent, J., . . . Ghiringhelli, F. (2016). Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma. Oncotarget.
Chicago Stili AlıntıBertaut, Aurélie, et al. "Blood Baseline Neutrophil Count Predicts Bevacizumab Efficacy in Glioblastoma." Oncotarget 2016.
MLA AlıntıBertaut, Aurélie, et al. "Blood Baseline Neutrophil Count Predicts Bevacizumab Efficacy in Glioblastoma." Oncotarget 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..